High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A...

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Nanomedicine

Background:

• The link between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease (CVD) remains debated.
• HDL particles are heterogeneous, comprising diverse subclasses with varying functions.
• HDL-C levels may not accurately reflect the cardioprotective capabilities of HDL.

Purpose of the Study:

• To review methods for separating HDL subclasses.
• To examine the association between HDL subclasses and cardiovascular risk (CVR).
• To explore the impact of interventions on HDL subclasses and their use in recombinant HDL (rHDL) therapies.

Main Methods:

• Literature review of studies on HDL subclass separation.
• Analysis of research on HDL subclasses and CVR.
• Evaluation of studies on pharmacological and non-pharmacological interventions affecting HDL subclasses.
• Review of rHDL applications in drug delivery.

Main Results:

• HDL subclasses exhibit differential associations with CVR.
• Lipid-modifying medications, exercise, diet, and apheresis impact HDL subclasses.
• Specific HDL subclasses are suitable for developing rHDLs for targeted delivery.

Conclusions:

• HDL subclasses provide a more accurate assessment of cardioprotective potential than HDL-C alone.
• Understanding HDL subclasses is crucial for developing novel CVD therapies.
• rHDLs represent a promising nanoplatform for in vivo applications.